What is the current price and volume for 4597.T stock pre-market?

Pre-market on 18 Mar 2026, 4597.T stock is at **JPY 32.00** with volume **41,691,300** shares, above average volume **31,322,228** which signals heightened trader interest.

How does Solasia’s valuation look versus its sector for 4597.T stock?

4597.T stock trades at price/sales **19.64** and price/book **5.17**, higher than Healthcare sector averages (PE **23.62**). Valuation reflects pipeline premium but also earnings weakness (EPS **-8.96**).

What forecast does Meyka AI give for 4597.T stock?

Meyka AI's forecast model projects monthly **JPY 32.39** (+1.22%) and yearly **JPY 25.66** (-19.81% vs current). Forecasts are model-based projections and not guarantees.

What are the main risks for 4597.T stock investors?

Main risks for 4597.T stock are negative clinical readouts, trial delays, and valuation compression given low revenue per share **JPY 1.52** and negative EPS. Liquidity is strong but volatility can be high around catalysts.

JP Stocks

4597.T Solasia Pharma (JPX) JPY 32.00 pre-market most-active: catalysts to watch 18 Mar 2026

ByHuzaifa Zahoor March 18, 2026March 18, 2026

4597.T stock is trading at JPY 32.00 in pre-market action on 18 Mar 2026 after heavy turnover of 41,691,300 shares. We flag Solasia Pharma K.K. (4597.T) on the JPX as one of Japan’s most active healthcare names this session. Price sits between a day low of JPY 31.00 and high of JPY 33.00, with a 50‑day average of JPY 30.58 and 200‑day average JPY 33.99. Investors are parsing clinical milestones for SP‑05 and cash runway metrics while traders track elevated liquidity and volatility in JPY.